117 related articles for article (PubMed ID: 8224086)
1. Trypanosoma brucei rhodesiense: the inhibition of HL-60 cell growth by the African trypanosomes in vitro.
Keku TO; Seed JR; Sechelski JB; Balber A
Exp Parasitol; 1993 Nov; 77(3):306-14. PubMed ID: 8224086
[TBL] [Abstract][Full Text] [Related]
2. [Human African trypanosomiasis].
Dumas M; Bouteille B
C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
[TBL] [Abstract][Full Text] [Related]
3. African trypanosomes: intracellular trafficking of host defense molecules.
Shiflett AM; Faulkner SD; Cotlin LF; Widener J; Stephens N; Hajduk SL
J Eukaryot Microbiol; 2007; 54(1):18-21. PubMed ID: 17300512
[TBL] [Abstract][Full Text] [Related]
4. Expression of alternative oxidase inhibits programmed cell death-like phenomenon in bloodstream form of Trypanosoma brucei rhodesiense.
Tsuda A; Witola WH; Ohashi K; Onuma M
Parasitol Int; 2005 Dec; 54(4):243-51. PubMed ID: 16115792
[TBL] [Abstract][Full Text] [Related]
5. The trypanolytic factor of human serum.
Pays E; Vanhollebeke B; Vanhamme L; Paturiaux-Hanocq F; Nolan DP; Pérez-Morga D
Nat Rev Microbiol; 2006 Jun; 4(6):477-86. PubMed ID: 16710327
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis.
Hertz CJ; Mansfield JM
Cell Immunol; 1999 Feb; 192(1):24-32. PubMed ID: 10066343
[TBL] [Abstract][Full Text] [Related]
7. Detection of T.b. rhodesiense trypanosomes in humans and domestic animals in south east Uganda by amplification of serum resistance-associated gene.
Enyaru JC; Matovu E; Nerima B; Akol M; Sebikali C
Ann N Y Acad Sci; 2006 Oct; 1081():311-9. PubMed ID: 17135530
[TBL] [Abstract][Full Text] [Related]
8. [Distribution and spread of human African trypanosomiasis: value of genetic identification of the trypanosomes].
Truc P; Cuny G
Med Trop (Mars); 2001; 61(4-5):433-6. PubMed ID: 11803837
[TBL] [Abstract][Full Text] [Related]
9. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
10. The trypanolytic factor-mechanism, impacts and applications.
Wheeler RJ
Trends Parasitol; 2010 Sep; 26(9):457-64. PubMed ID: 20646962
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of methionine transport and metabolism by Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
Goldberg B; Rattendi D; Lloyd D; Yarlett N; Bacchi CJ
Arch Biochem Biophys; 2000 May; 377(1):49-57. PubMed ID: 10775440
[TBL] [Abstract][Full Text] [Related]
12. An RNAi screen of the RRM-domain proteins of Trypanosoma brucei.
Wurst M; Robles A; Po J; Luu VD; Brems S; Marentije M; Stoitsova S; Quijada L; Hoheisel J; Stewart M; Hartmann C; Clayton C
Mol Biochem Parasitol; 2009 Jan; 163(1):61-5. PubMed ID: 18840477
[TBL] [Abstract][Full Text] [Related]
13. The in vitro HL-60 cell--Trypanosoma brucei rhodesiense culture system: a rapid in vitro drug screen.
Keku TO; Seed JR; Tidwell RR
Trop Med Parasitol; 1995 Dec; 46(4):258-62. PubMed ID: 8826107
[TBL] [Abstract][Full Text] [Related]
14. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins.
Schleifer KW; Mansfield JM
J Immunol; 1993 Nov; 151(10):5492-503. PubMed ID: 8228241
[TBL] [Abstract][Full Text] [Related]
15. The trypanosome lytic factor of human serum and the molecular basis of sleeping sickness.
Vanhamme L; Pays E
Int J Parasitol; 2004 Jul; 34(8):887-98. PubMed ID: 15217727
[TBL] [Abstract][Full Text] [Related]
16. A multiplex PCR that discriminates between Trypanosoma brucei brucei and zoonotic T. b. rhodesiense.
Picozzi K; Carrington M; Welburn SC
Exp Parasitol; 2008 Jan; 118(1):41-6. PubMed ID: 17643434
[TBL] [Abstract][Full Text] [Related]
17. Human African trypanosomiasis: connecting parasite and host genetics.
Garcia A; Courtin D; Solano P; Koffi M; Jamonneau V
Trends Parasitol; 2006 Sep; 22(9):405-9. PubMed ID: 16837245
[TBL] [Abstract][Full Text] [Related]
18. Anti-Trypanosoma brucei activity in Cape buffalo serum during the cryptic phase of parasitemia is mediated by antibodies.
Guirnalda P; Murphy NB; Nolan D; Black SJ
Int J Parasitol; 2007 Oct; 37(12):1391-9. PubMed ID: 17583714
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host Anemia.
Szempruch AJ; Sykes SE; Kieft R; Dennison L; Becker AC; Gartrell A; Martin WJ; Nakayasu ES; Almeida IC; Hajduk SL; Harrington JM
Cell; 2016 Jan; 164(1-2):246-257. PubMed ID: 26771494
[TBL] [Abstract][Full Text] [Related]
20. Are fitness costs associated with resistance to human serum in Trypanosoma brucei rhodesiense?
Coleman PG; Welburn SC
Trends Parasitol; 2004 Jul; 20(7):311-5. PubMed ID: 15193561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
